nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—Stomach ache—Octreotide—thymus cancer	0.0717	0.0717	CcSEcCtD
Alfuzosin—Neuralgia—Octreotide—thymus cancer	0.0439	0.0439	CcSEcCtD
Alfuzosin—Influenza-like symptoms—Octreotide—thymus cancer	0.0427	0.0427	CcSEcCtD
Alfuzosin—Cholestasis—Octreotide—thymus cancer	0.0401	0.0401	CcSEcCtD
Alfuzosin—Nephrolithiasis—Octreotide—thymus cancer	0.0379	0.0379	CcSEcCtD
Alfuzosin—Arthropathy—Octreotide—thymus cancer	0.0335	0.0335	CcSEcCtD
Alfuzosin—Influenza like illness—Octreotide—thymus cancer	0.0296	0.0296	CcSEcCtD
Alfuzosin—Neuropathy—Octreotide—thymus cancer	0.0286	0.0286	CcSEcCtD
Alfuzosin—Injury—Octreotide—thymus cancer	0.0241	0.0241	CcSEcCtD
Alfuzosin—Arthritis—Octreotide—thymus cancer	0.0228	0.0228	CcSEcCtD
Alfuzosin—Osteoarthritis—Octreotide—thymus cancer	0.0221	0.0221	CcSEcCtD
Alfuzosin—Abdominal pain upper—Octreotide—thymus cancer	0.0202	0.0202	CcSEcCtD
Alfuzosin—Bronchitis—Octreotide—thymus cancer	0.0184	0.0184	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Octreotide—thymus cancer	0.0178	0.0178	CcSEcCtD
Alfuzosin—Drowsiness—Octreotide—thymus cancer	0.017	0.017	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Octreotide—thymus cancer	0.0167	0.0167	CcSEcCtD
Alfuzosin—Jaundice—Octreotide—thymus cancer	0.0166	0.0166	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Octreotide—thymus cancer	0.0161	0.0161	CcSEcCtD
Alfuzosin—Sinusitis—Octreotide—thymus cancer	0.016	0.016	CcSEcCtD
Alfuzosin—Rhinitis—Octreotide—thymus cancer	0.0153	0.0153	CcSEcCtD
Alfuzosin—Pharyngitis—Octreotide—thymus cancer	0.0152	0.0152	CcSEcCtD
Alfuzosin—Flushing—Octreotide—thymus cancer	0.0142	0.0142	CcSEcCtD
Alfuzosin—Cardiac disorder—Octreotide—thymus cancer	0.0142	0.0142	CcSEcCtD
Alfuzosin—Mental disorder—Octreotide—thymus cancer	0.0134	0.0134	CcSEcCtD
Alfuzosin—Back pain—Octreotide—thymus cancer	0.0129	0.0129	CcSEcCtD
Alfuzosin—Ill-defined disorder—Octreotide—thymus cancer	0.0124	0.0124	CcSEcCtD
Alfuzosin—Malaise—Octreotide—thymus cancer	0.012	0.012	CcSEcCtD
Alfuzosin—Vertigo—Octreotide—thymus cancer	0.012	0.012	CcSEcCtD
Alfuzosin—Syncope—Octreotide—thymus cancer	0.0119	0.0119	CcSEcCtD
Alfuzosin—Palpitations—Octreotide—thymus cancer	0.0118	0.0118	CcSEcCtD
Alfuzosin—Loss of consciousness—Octreotide—thymus cancer	0.0117	0.0117	CcSEcCtD
Alfuzosin—Chest pain—Octreotide—thymus cancer	0.0113	0.0113	CcSEcCtD
Alfuzosin—Arthralgia—Octreotide—thymus cancer	0.0113	0.0113	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.0113	0.0113	CcSEcCtD
Alfuzosin—Discomfort—Octreotide—thymus cancer	0.0112	0.0112	CcSEcCtD
Alfuzosin—Dry mouth—Octreotide—thymus cancer	0.0111	0.0111	CcSEcCtD
Alfuzosin—Oedema—Octreotide—thymus cancer	0.0109	0.0109	CcSEcCtD
Alfuzosin—Infection—Octreotide—thymus cancer	0.0108	0.0108	CcSEcCtD
Alfuzosin—Shock—Octreotide—thymus cancer	0.0107	0.0107	CcSEcCtD
Alfuzosin—Nervous system disorder—Octreotide—thymus cancer	0.0107	0.0107	CcSEcCtD
Alfuzosin—Thrombocytopenia—Octreotide—thymus cancer	0.0106	0.0106	CcSEcCtD
Alfuzosin—Tachycardia—Octreotide—thymus cancer	0.0106	0.0106	CcSEcCtD
Alfuzosin—Skin disorder—Octreotide—thymus cancer	0.0106	0.0106	CcSEcCtD
Alfuzosin—Hyperhidrosis—Octreotide—thymus cancer	0.0105	0.0105	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Octreotide—thymus cancer	0.0099	0.0099	CcSEcCtD
Alfuzosin—Somnolence—Octreotide—thymus cancer	0.00966	0.00966	CcSEcCtD
Alfuzosin—Dyspepsia—Octreotide—thymus cancer	0.00957	0.00957	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Octreotide—thymus cancer	0.00938	0.00938	CcSEcCtD
Alfuzosin—Fatigue—Octreotide—thymus cancer	0.00937	0.00937	CcSEcCtD
Alfuzosin—Pain—Octreotide—thymus cancer	0.0093	0.0093	CcSEcCtD
Alfuzosin—Constipation—Octreotide—thymus cancer	0.0093	0.0093	CcSEcCtD
Alfuzosin—Feeling abnormal—Octreotide—thymus cancer	0.00896	0.00896	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Octreotide—thymus cancer	0.00889	0.00889	CcSEcCtD
Alfuzosin—Urticaria—Octreotide—thymus cancer	0.00864	0.00864	CcSEcCtD
Alfuzosin—Abdominal pain—Octreotide—thymus cancer	0.00859	0.00859	CcSEcCtD
Alfuzosin—Asthenia—Octreotide—thymus cancer	0.0078	0.0078	CcSEcCtD
Alfuzosin—Pruritus—Octreotide—thymus cancer	0.00769	0.00769	CcSEcCtD
Alfuzosin—Diarrhoea—Octreotide—thymus cancer	0.00744	0.00744	CcSEcCtD
Alfuzosin—Dizziness—Octreotide—thymus cancer	0.00719	0.00719	CcSEcCtD
Alfuzosin—Vomiting—Octreotide—thymus cancer	0.00691	0.00691	CcSEcCtD
Alfuzosin—Rash—Octreotide—thymus cancer	0.00685	0.00685	CcSEcCtD
Alfuzosin—Dermatitis—Octreotide—thymus cancer	0.00685	0.00685	CcSEcCtD
Alfuzosin—Headache—Octreotide—thymus cancer	0.00681	0.00681	CcSEcCtD
Alfuzosin—Nausea—Octreotide—thymus cancer	0.00646	0.00646	CcSEcCtD
